Repligen (RGEN)
(Real Time Quote from BATS)
$161.16 USD
-0.51 (-0.32%)
Updated Aug 5, 2024 02:50 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (91 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.54 | 1.35 | 9.99 |
Current Quarter Estimate | 0.33 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 0.23 | 0.12 | 54.84 |
Next Quarter Estimate | 0.50 | 7.81 | 63.00 |
Next Year Estimate | 1.99 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -17.14 | 16.20 | 15.67 |
Next Year | 37.24 | 10.00 | 11.34 |
Last 5 Years | 15.90 | 1.00 | 8.10 |
Next 5 Years | 19.40 | 20.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 138.18 | -2.18 |
Price/Book (MRQ) | 4.56 | 2.20 |
Price/Cash Flow (MRFY) | 53.43 | 16.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -0.32% | -12.31% |
Return on Equity (TTM) | 3.36% | -15.05% |
Debt to Equity (MRQ) | 0.26 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.